Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.39K Hold
80
﹤0.01% 633
2026
Q1
$5.02K Buy
+80
New +$5.57K ﹤0.01% 630
2025
Q4
Sell
-80
Closed -$5.38K 230
2025
Q3
$5.38K Hold
80
﹤0.01% 606
2025
Q2
$6.98K Hold
80
﹤0.01% 533
2025
Q1
$5.46K Hold
80
﹤0.01% 582
2024
Q4
$6.22K Hold
80
﹤0.01% 557
2024
Q3
$5.36K Hold
80
﹤0.01% 580
2024
Q2
$8.97K Hold
80
﹤0.01% 536
2024
Q1
$11K Hold
80
﹤0.01% 519
2023
Q4
$9.93K Buy
+80
New +$8.17K ﹤0.01% 803

Other funds holding DXCM

Main Street Group's DXCM Position: Q2 2026 in Review

Main Street Group held its DexCom (DXCM) position steady in Q2 2026 at 80 shares worth $5.39K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Main Street Group first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $11K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Main Street Group held 80 shares of DexCom worth $5.39K as of Q2 2026.
  • Main Street Group left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #633 holding.
  • Main Street Group first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's DexCom position peaked at $11K in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.